HSCT provides effective treatment for lymphoproliferative disorders in children with primary immunodeficiency - 05/08/20

Doi : 10.1016/j.jaci.2020.03.043

Giulia Prunotto, MD ^a,^{^{∗
Co-first authors: These authors contributed equally to this work.}}, Ugonna T. Offor, MD ^b,^c,^{^{∗
Co-first authors: These authors contributed equally to this work.}}, Sujith Samarasinghe, MD ^d, Robert Wynn, MD ^e, Ajay Vora, MD ^d, Ben Carpenter, MD ^f, Claire Gowdy, MD ^g, Kieran McHugh, MD ^h, Kevin P. Windebank, MD ^c, Attilio Maria Rovelli, MD ^a, Mary A. Slatter, MD ⁱ, Andrew R. Gennery, MD ^i,^j, Paul Veys, MD ^k, Chris M. Bacon, MD ^b,^l, Simon Bomken, MD ^b,^c,^{^{‡
Co-senior authors: These authors contributed equally to this work.}}, Giovanna Lucchini, MD ^k,^{^{‡
Co-senior authors: These authors contributed equally to this work.}}
^a Bone Marrow Transplantation Unit, Pediatric Department of Milano-Bicocca University, Monza e Brianza per il Bambino e la sua Mamma Foundation, Monza, Italy
^b Wolfson Childhood Cancer Research Centre, Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom
^c Department of Paediatric Haematology and Oncology, The Great North Children’s Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
^d Haematology Department, Great Ormond Street Hospital NHS Trust, London, United Kingdom
^e Department of Blood and Marrow Transplantation, Royal Manchester Children’s Hospital, Manchester, United Kingdom
^f University College London Hospital, London, United Kingdom
^g Department of Radiology, Royal Belfast Hospital for Sick Children, Belfast, United Kingdom
^h Radiology Department, Great Ormond Street Hospital NHS Trust, London, United Kingdom
ⁱ Department of Paediatric Immunology and Haematopoietic Stem Cell Transplantation, Great North Children’s Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
^j Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom
^k BMT Department, Great Ormond Street Hospital NHS Trust, London, United Kingdom
^l Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom

	This project was generously supported in part by a research grant (grant no. CCLGA 2017 16) from the Children's Cancer and Leukaemia Group and The Little Princess Trust.
	Disclosure of potential conflicts of interest: The authors declare that they have no relevant conflicts of interest.

Esportazione

Vol 146 - N° 2

P. 447-450 - Agosto 2020 Ritorno al numero

Articolo precedente

Hormonal contraceptives and onset of asthma in reproductive-age women: Population-based cohort study
Bright I. Nwaru, Rebecca Pillinger, Holly Tibble, Syed A. Shah, Dermot Ryan, Hilary Critchley, David Price, Catherine M. Hawrylowicz, Colin R. Simpson, Ireneous N. Soyiri, Francis Appiagyei, Aziz Sheikh

| Articolo seguente

Glycolipid-mediated basophil activation in alpha-gal allergy
Onyinye I. Iweala, Shailesh K. Choudhary, Claire T. Addison, Cole J. Batty, Camille M. Kapita, Claire Amelio, Alexander J. Schuyler, Shenglou Deng, Eric M. Bachelder, Kristy M. Ainslie, Paul B. Savage, Patrick J. Brennan, Scott P. Commins

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

connettersi o creare un account

HSCT provides effective treatment for lymphoproliferative disorders in children with primary immunodeficiency - 05/08/20

Citazioni Export

File

Contenuto

Il mio account

Aide & support

Dichiarazione CNIL